Iterative Health key facts
as of Oct 2026- Developer of a clinical research site network designed to speed up gastroenterology studies.
- Iterative Health is valued at approximately $1.4B as of Oct 2026 (last reported valuation).
- It has raised $271.1M; the latest was Later Stage VC ($75.0M) in Feb 2026.
- Notable investors include Plug and Play Tech Center, Alumni Ventures, MedTech Innovator, Insight Partners (New York), Texas Medical Center — 34 tracked in total.
- Status: Privately Held (backing).
Iterative Health's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·The complete investor list: 34 names
- ·Watch Iterative Health: the Monday email on marks, rounds and moves
Iterative Health funding rounds
No funding rounds for Iterative Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Iterative Health
34+Iterative Health valuation
Iterative Health's last reported valuation was $1.4 billion in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
Iterative Health investors
34 investors are on record for Iterative Health, including Plug and Play Tech Center, Alumni Ventures, MedTech Innovator and Insight Partners (New York). By type, the record holds 11 venture capital firms and 2 private equity firms.
About Iterative Health
Developer of a clinical research site network designed to speed up gastroenterology studies. The company offers a platform powered by artificial intelligence, broad site access and efficient patient recruitment, enabling pharmaceutical and biotechnology companies to complete trials more quickly than usual.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2017
- Employees
- 144
- Website
- iterative.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.